dalteparin has been researched along with Placental Insufficiency in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Placental Insufficiency: Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of intrauterine growth restriction (IUGR) is estimated at about 3% of pregnancies, and it is associated with 30% of all perinatal mortality and severe morbidity with adverse neurodevelopmental and cardiovascular health consequences in adult life." | 2.87 | Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP). ( Camprubí, M; Figueras, F; Gomez Roig, MD; Ibáñez-Burillo, P; Masoller, N; Mazarico, E; Oros, D; Peguero, A; Rovira, C; Schoorlemmer, J; Tàssies, MD, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazarico, E | 1 |
| Peguero, A | 1 |
| Camprubí, M | 1 |
| Rovira, C | 1 |
| Gomez Roig, MD | 1 |
| Oros, D | 1 |
| Ibáñez-Burillo, P | 1 |
| Schoorlemmer, J | 1 |
| Masoller, N | 1 |
| Tàssies, MD | 1 |
| Figueras, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Intrauterine Growth Restriction With Low Molecular Heparin: Randomized Clinical Trial. Tratamiento Del Crecimiento Intrauterino Restringido Precoz Con Heparina de Bajo Peso Molecular: Ensayo clínico Aleatorizado.[NCT03324139] | Phase 3 | 50 participants (Anticipated) | Interventional | 2017-10-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dalteparin and Placental Insufficiency
| Article | Year |
|---|---|
Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP).
Topics: Female; Fetal Growth Retardation; Gestational Age; Heparin, Low-Molecular-Weight; Humans; Infant, Ne | 2018 |